LUPIN
Back to Cashflow Statement
|
LUPIN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1,732 Cr | ₹-2,184 Cr | ₹-337 Cr | ₹-1,572 Cr | ₹-1,885 Cr |
What is the latest Cash Flow from Financing Activities ratio of LUPIN ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹1,732 Cr |
| Mar2024 | ₹-2,184 Cr |
| Mar2023 | ₹-337 Cr |
| Mar2022 | ₹-1,572 Cr |
| Mar2021 | ₹-1,885 Cr |
How is Cash Flow from Financing Activities of LUPIN Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,732 Cr | Positive | |
| Mar2024 | ₹-2,184 Cr | Negative | |
| Mar2023 | ₹-337 Cr | Negative | |
| Mar2022 | ₹-1,572 Cr | Negative | |
| Mar2021 | ₹-1,885 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LUPIN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LUPIN | ₹103,896.4 Cr | -0.3% | -1.3% | 15% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
LUPIN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LUPIN | -0.3% |
-1.3% |
15% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses